Surgical oncology device developer Onkos Surgical said today it closed a $17.6 million Series B financing round.
Money in the round will support the expansion of the Parsippany, N.J.-based company’s sales, marketing and R&D platforms. The round was led by Canaan Partners and joined by existing investors 1315 Capital and 3D Systems.
“The Onkos team brings unmatched experience and commitment to serving the challenges and needs of the surgical oncology community. Patients and physicians trust Patrick Treacy and his Onkos colleagues to translate those clinical needs into innovative products that improve patient care,” Bloch said in a press release.
As part of the funding round, Canaan Partners GP Stephen Bloch will join Onkos Surgical’s board of directors.
“Every day, musculoskeletal oncologists and their patients are faced with clinical challenges that have been overlooked for too long. We have the portfolio to deliver meaningful innovation with our advanced 3D printing capabilities, limb restoration technologies, and biologic solutions – all enabled with a unique service and surgical planning platform called uDesign Patient Solutions. The addition of leading investor Canaan Partners to our roster of investors further validates our opportunity to serve this unique and underserved market. The combined intellectual capital and operating experience that Canaan Partners, 1315 Capital and 3D Systems provides to our leadership team will enable us to scale our business rapidly and efficiently,” co-founder & CEO Patrick Treacy said in a press release.
